Serotonin-Norepinephrine Reuptake Inhibitors

URI: https://gptkb.org/entity/Serotonin-Norepinephrine_Reuptake_Inhibitors
GPTKB entity
Statements (32)
Predicate Object
gptkbp:instanceOf class of antidepressant drugs
gptkbp:abbreviation gptkb:SNRIs
gptkbp:category benzodiazepine
antidepressant
psychotropic medication
gptkbp:contraindication uncontrolled hypertension
concurrent use with MAOIs
gptkbp:contrastsWith gptkb:SSRIs
gptkbp:example gptkb:venlafaxine
gptkb:desvenlafaxine
gptkb:levomilnacipran
gptkb:milnacipran
gptkb:duloxetine
https://www.w3.org/2000/01/rdf-schema#label Serotonin-Norepinephrine Reuptake Inhibitors
gptkbp:introducedIn 1990s
gptkbp:mechanismOfAction inhibit reuptake of serotonin and norepinephrine
gptkbp:notable_for affect both serotonin and norepinephrine
gptkbp:regulates prescription only
gptkbp:riskFactor gptkb:discontinuation_syndrome
gptkb:serotonin_syndrome
gptkbp:routeOfAdministration oral
gptkbp:sideEffect nausea
dizziness
insomnia
dry mouth
sexual dysfunction
increased blood pressure
gptkbp:usedFor gptkb:major_depressive_disorder
chronic pain
anxiety disorders
gptkbp:bfsParent gptkb:SNRIs
gptkbp:bfsLayer 7